Furthermore, a combination of IDO1 or AhR inhibitors to block this pathway and IFN-β treatment significantly decreased colony size and colony number of tumor cells, due to dormant tumor cells that were abrogated, which provided a novel and ideal treatment against cancer dormancy (83). Here, IDO1 is linked to neoplasm.